Antibiotics prior to immune checkpoint inhibitor therapy worsens survival in Merkel cell carcinoma: A TriNetX retrospective cohort study
Authors:
Open Access
- 21 March 2026
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (1) , 271-274
Abstract
No abstract availableFunding Information
- National Center for Advancing Translational Sciences
- National Institutes of Health (UM1TR004528)
This publication has 5 references indexed in Scilit:
- Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitorsEuropean Journal of Cancer, 2025
- Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEuropean Journal of Cancer, 2024
- Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adultsCell Reports, 2022
- The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving ImmunotherapyJNCI: Journal of the National Cancer Institute, 2022
- Merkel Cell Carcinoma Masquerading As Cellulitis: A Case Report and Review of the LiteratureCurrent Oncology, 2018